FDA selects Ingenix fpr drug safety monitoring and support(10/04/2005) New Technology to Help Accelerate Identification of Drug Safety Signals Ingenix, a wholly owned subsidiary of UnitedHealth Group has been selected by the United States Food and Drug Administration (FDA) to help improve the effectiveness and speed of safety evaluations for pharmaceutical agents. The Ingenix program is ...
i3 Research Acquires SKM Oncology(06/27/2005) i3 Research, a global contract research organization (CRO) providing clinical trial services specialized in oncology, central nervous system, respiratory and infectious disease, has acquired SKM Oncology and its related businesses. SKM is a ...
Top